Your session is about to expire
← Back to Search
DiNaMo Study App for Fibromyalgia
Study Summary
CT-100 is a platform that provides interactive, software based therapeutic components that may be used as part of a multimodal treatment in supplementary or standalone prescription or nonprescription software-based digital therapeutics (PDT/DTx), being developed by Click Therapeutics, Inc. (Click).
- Fibromyalgia
- Diabetic Neuropathy
- Rheumatoid Arthritis
- Irritable Bowel Syndrome
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Could you approximate the aggregate of participants in this trial?
"Affirmative. According to the information found on clinicaltrials.gov, this trial is actively looking for participants and was initially posted October 10th 2022. The study seeks 120 individuals at 2 medical centres."
Does this experimental procedure accept individuals aged 45 and older?
"The cut-off for enrolment in this trial is 18 years old and the upper age limit has been set at 65."
Is there an opportunity to join this research endeavor?
"This investigation is searching for 120 individuals aged 18 to 65 suffering from rheumatoid arthritis. To qualify, patients must have fluency in English (as certified by the comprehension of Informed Consent Forms), possess an active email address and be willing to receive messages, own a phone with either iOS 14 or higher or Android OS 10 or above that can access cellular/internet connection throughout the study duration, comply with indication-specific criteria corroborated through clinical history, exhibit moderate pain intensity as reported on NRS scale over 7 days prior to screening survey completion, agree to follow all protocol requirements and reside in the United States."
Are applications still being accepted for participation in this research?
"Affirmative. The information published on clinicaltrials.gov confirms that this research endeavour, initially posted on October 10th 2022, is actively recruiting volunteers. Approximately 120 participants are required from two different sites."
Share this study with friends
Copy Link
Messenger